BioSpace News Archive

Ziopharm Oncology, Inc., issued a statement in connection with the consent solicitation initiated by WaterMill Asset Management Corp., Mr. Robert W. Postma and certain other individuals following the delay of the original December 11 deadline set by WaterMill for Ziopharm shareholders to deliver written consents in support of the Consent Solicitation.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), announced today that it has secured $950,000 in bridge financing and simultaneously filed with the SEC to become a mandatory, fully reporting company.

Doheny Eye Institute is excited to announce the official transition from the design phase to commencing the interior build-construction and renovation of its future home at 150 North Orange Grove Boulevard in Pasadena, California.

The announcement from the FDA providing Pfizer with emergency use authorization on its COVID-19 vaccine is a historic milestone and important step toward ending the pandemic.

Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide’s clinical trial for the treatment of COVID-19.

Today, the U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older

The leaders of 18 pharmacy organizations issued the following statement following the Food and Drug Administration’s approval of the first Emergency use Authorization for the COVID-19 vaccine.

U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediately